Lung Cancer Screening

Overview

4.7 out of 5 (24 Reviews)

Credits

1.00

Post Assessment Questions

6

Start Date

1 Jan 2021

Last Review Date

24 Jul 2023

Expiration Date

31 Dec 2023

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Worldwide lung cancer has the highest rate of mortality and is the leading cause of cancer deaths. The incidence of lung cancer is approximately equal to its mortality. There are approximately 1.8 million new cases of lung cancer every year globally and over 1.6 million deaths secondary to this. The survival rates for lung cancer are abysmal, in the United States the overall 5-year survival is as low as 18% which is in sharp contrast to the high rates of survival for breast, colon, and prostate cancer at 90, 65 and almost 100% respectively. These low rates of survival link directly with most lung cancers only getting diagnosed when the disease is in advanced stages. Before screening interventions, lung cancers in early stages were found mostly as a coincidental finding. Due to the late presentation of these patients, survival beyond a few years was not possible. Due to these problems, there was a global push for screening modalities for lung cancer to ensure the identification of malignancy occurred earlier in the disease process. The average 5-year survival in the United States of patients with lung cancer is 17.7%; however, this number drastically changes if we account for the stage of the disease at the time of diagnosis. In patients with localized disease, the survival rates are as high as 55.2%. However, only 16% of patients get diagnosed at this early stage of their disease. This difference in survival rates further highlights the absolute need for a reliable screening tool for patients at risk for lung cancer. This activity reviews the considerations for lung cancer screening and discusses the role of the interprofessional team in considering the limited screen tools available for patients at higher risk.


Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Describe the leading cause of cancer deaths worldwide.

  • Review the survival rates of lung cancer.

  • Outline the challenges and methods of early diagnosis of lung cancer.

  • Summarize the considerations for lung cancer screening and outline the role of the interprofessional team in considering the limited screen tools available for patients at higher risk.

Disclosures

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they or their immediate family may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CUSOM for resolution, to ensure fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

CUSOM will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for authors, editors, planners, peer reviewers, and/or relevant staff is provided with this activity.

Continuing Education Accreditation Information

 

 

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. CUSOM designates this enduring material for a maximum of 1.00 AOA Category 1 B Credits and will report CME credits commensurate with the extent of the physician's participation in the activity.

Cancellation Policy: Cancellations must be received in writing and a money back guarantee is provided if not completely satisfied.

  • StatPearls and CUSOM reserve the right to cancel any course due to unforeseen circumstances. StatPearls and CUSOM will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and CUSOM are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and CUSOM adheres to AOA Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and Campbell that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

This course is intended for osteopathic physicians who wish to earn AOA CME credit. Take this version of the course to ensure you receive appropriate credit.

 

 
 

Reviews

Sandeep S. on 5/8/2021

Paul F. on 7/21/2021

Deborah Z. on 8/13/2021

Mike G. on 9/3/2021

Yewande A. on 10/30/2021

Susan B. on 4/9/2022

Christina M. on 8/13/2022

Elisabeth H. on 9/3/2022

Michael D. on 2/4/2023

Melanie P. on 3/20/2023

Laxmi S. on 6/8/2023

Vincent B. on 7/21/2023

Jodi H. on 9/20/2023

Preeti P. on 11/7/2023

Sharon D. on 11/16/2023

Padmini N. on 11/25/2023

Yaakov W. on 12/13/2023

Great review.

Richard P. on 12/17/2023

Arnbjorn T. on 12/19/2023

Padmini N. on 1/17/2024

Steven L. on 1/23/2024

Tyler S. on 2/1/2024

Fariborz M. on 3/7/2024

joerg r. on 3/19/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$39 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user